Free Trial

PAVmed (PAVM) Stock Price, News & Analysis

PAVmed logo
$0.60 0.00 (-0.45%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$0.60 0.00 (-0.05%)
As of 07/11/2025 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About PAVmed Stock (NASDAQ:PAVM)

Key Stats

Today's Range
$0.58
$0.60
50-Day Range
$0.55
$0.77
52-Week Range
$0.54
$1.90
Volume
27,731 shs
Average Volume
137,186 shs
Market Capitalization
$10.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.00
Consensus Rating
Buy

Company Overview

PAVmed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
81st Percentile Overall Score

PAVM MarketRank™: 

PAVmed scored higher than 81% of companies evaluated by MarketBeat, and ranked 127th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    PAVmed has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    PAVmed has only been the subject of 1 research reports in the past 90 days.

  • Read more about PAVmed's stock forecast and price target.
  • Percentage of Shares Shorted

    2.35% of the float of PAVmed has been sold short.
  • Short Interest Ratio / Days to Cover

    PAVmed has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in PAVmed has recently increased by 1.57%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    PAVmed does not currently pay a dividend.

  • Dividend Growth

    PAVmed does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.35% of the float of PAVmed has been sold short.
  • Short Interest Ratio / Days to Cover

    PAVmed has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in PAVmed has recently increased by 1.57%, indicating that investor sentiment is decreasing.
  • News Sentiment

    PAVmed has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for PAVmed this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, PAVmed insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 7.30% of the stock of PAVmed is held by insiders.

  • Percentage Held by Institutions

    Only 19.93% of the stock of PAVmed is held by institutions.

  • Read more about PAVmed's insider trading history.
Receive PAVM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PAVmed and its competitors with MarketBeat's FREE daily newsletter.

PAVM Stock News Headlines

PAVmed Inc
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
See More Headlines

PAVM Stock Analysis - Frequently Asked Questions

PAVmed's stock was trading at $0.6275 on January 1st, 2025. Since then, PAVM shares have decreased by 4.8% and is now trading at $0.5973.

PAVmed Inc. (NASDAQ:PAVM) posted its quarterly earnings data on Thursday, August, 12th. The company reported ($2.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.50) by $0.60.
Read the conference call transcript
.

PAVmed shares reverse split before market open on Thursday, December 7th 2023.The 1-15 reverse split was announced on Thursday, December 7th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of PAVM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that PAVmed investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), CrowdStrike (CRWD), Pfizer (PFE).

Company Calendar

Last Earnings
8/12/2021
Today
7/12/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:PAVM
CIK
1624326
Fax
N/A
Employees
90
Year Founded
N/A

Price Target and Rating

High Price Target
$19.00
Low Price Target
$19.00
Potential Upside/Downside
+3,081.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.71
Trailing P/E Ratio
0.84
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$39.79 million
Net Margins
3,711.54%
Pretax Margin
3,289.61%
Return on Equity
N/A
Return on Assets
-42.29%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.37
Quick Ratio
0.37

Sales & Book Value

Annual Sales
$2.99 million
Price / Sales
3.41
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.92) per share
Price / Book
-0.65

Miscellaneous

Outstanding Shares
17,090,000
Free Float
15,845,000
Market Cap
$10.21 million
Optionable
Optionable
Beta
1.06

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:PAVM) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners